DOYLE MITTIE

PrivateCIK: 1918845
Location

SOUTH SAN FRANCISCO, CA

DOYLE MITTIE (Chief Medical Officer) sold 8.2% of their position (4.65K shares) of AVALO THERAPEUTICS, INC. on the open market

Open‑market sale worth $93.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderDOYLE MITTIECIK 1918845
IssuerAVALO THERAPEUTICS, INC.CIK 1534120
Officer· Chief Medical Officer
Since Feb 2026
-4.65K
Net shares
Net seller
$93.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
4.65K acquired · 9.31K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+2.88K

Price / share

$12.65

Trade value

$36.37K

% of position

5.6%
6/30/2026
51.78K54.65K

Common Stock

Direct
M · Option Exercise

Shares

+1.78K

Price / share

$8.04

Trade value

$14.30K

% of position

3.3%
6/30/2026
54.65K56.43K

Common Stock

Direct
S · Sale

Shares

4.65K

Price / share

$20.00

Trade value

$93.08K

% of position

8.2%
6/30/2026
56.43K51.78K
Total

Net shares

+0.00

Net value

-$42.41K

Derivative Transactions2

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

2.88K shares

Shares

2.88K

Strike price

12.65

Held after

125.75K

Exercisable

6/30/2026

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

1.78K shares

Shares

1.78K

Strike price

8.04

Held after

115.09K

Exercisable

6/30/2026